相似文献
1
High-density tissue microarrays from prostate needle biopsies.
J Clin Pathol. 2011 Jan;64(1):88-90. doi: 10.1136/jcp.2010.082339. Epub 2010 Nov 15.
2
An improved method for constructing tissue microarrays from prostate needle biopsy specimens.
J Clin Pathol. 2009 Aug;62(8):694-8. doi: 10.1136/jcp.2009.065201.
3
Construction of tissue microarrays from prostate needle biopsy specimens.
Br J Cancer. 2005 Aug 22;93(4):478-82. doi: 10.1038/sj.bjc.6602726.
4
Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis.
Appl Immunohistochem Mol Morphol. 2015 May-Jun;23(5):364-73. doi: 10.1097/PAI.0000000000000085.
5
Construction of tissue micro array from prostate needle biopsies using the vertical clustering re-arrangement technique.
Prostate. 2011 Sep 15;71(13):1374-81. doi: 10.1002/pros.21352. Epub 2011 Feb 9.
6
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.
Prostate. 2018 Dec;78(16):1229-1237. doi: 10.1002/pros.23698. Epub 2018 Aug 2.
7
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.
Elife. 2021 Dec 23;10:e71265. doi: 10.7554/eLife.71265.
8
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.
Prostate Cancer Prostatic Dis. 2009;12(2):143-7. doi: 10.1038/pcan.2008.47. Epub 2008 Sep 2.
9
Protocols for Tissue Microarrays in Prostate Cancer Studies.
Methods Mol Biol. 2018;1786:103-116. doi: 10.1007/978-1-4939-7845-8_6.
10
Feasibility of constructing tissue microarrays from diagnostic prostate biopsies.
Prostate. 2007 Jul 1;67(10):1011-8. doi: 10.1002/pros.20603.
引用本文的文献
1
A Simplified Method of Manually Constructing Small Format Tissue Microarray for Use in Resource-Constrained Settings.
Iran J Pathol. 2023 Spring;18(2):210-216. doi: 10.30699/IJP.2023.562055.2972. Epub 2023 Jun 20.
2
Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer.
Clin Transl Radiat Oncol. 2018 Feb 16;10:1-6. doi: 10.1016/j.ctro.2018.02.002. eCollection 2018 Mar.
3
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):309-315. doi: 10.1016/j.ijrobp.2018.01.072. Epub 2018 Feb 3.
4
Overview on Techniques to Construct Tissue Arrays with Special Emphasis on Tissue Microarrays.
Microarrays (Basel). 2014 Apr 17;3(2):103-36. doi: 10.3390/microarrays3020103.
5
Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer.
Biomed Res Int. 2015;2015:238757. doi: 10.1155/2015/238757. Epub 2015 Oct 4.
6
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.
Br J Cancer. 2013 Feb 5;108(2):271-7. doi: 10.1038/bjc.2012.598. Epub 2013 Jan 17.
本文引用的文献
1
Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation.
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):35-41. doi: 10.1016/j.ijrobp.2009.07.1728. Epub 2010 Jan 21.
2
An improved method for constructing tissue microarrays from prostate needle biopsy specimens.
J Clin Pathol. 2009 Aug;62(8):694-8. doi: 10.1136/jcp.2009.065201.
3
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.
Prostate Cancer Prostatic Dis. 2009;12(2):143-7. doi: 10.1038/pcan.2008.47. Epub 2008 Sep 2.
4
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
Lancet Oncol. 2008 Apr;9(4):342-51. doi: 10.1016/S1470-2045(08)70076-7. Epub 2008 Mar 17.
5
Cancer statistics, 2006.
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
6
Construction of tissue microarrays from prostate needle biopsy specimens.
Br J Cancer. 2005 Aug 22;93(4):478-82. doi: 10.1038/sj.bjc.6602726.
7
Detection of prostate cancer and predicting progression: current and future diagnostic markers.
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3943-53. doi: 10.1158/1078-0432.CCR-03-0200.
8
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
Cancer Treat Rev. 2004 Apr;30(2):153-64. doi: 10.1016/j.ctrv.2003.10.001.
9
Standard for breast conservation therapy in the management of invasive breast carcinoma.
CA Cancer J Clin. 2002 Sep-Oct;52(5):277-300. doi: 10.3322/canjclin.52.5.277.
10
Oral cancer and precancerous lesions.
CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215. doi: 10.3322/canjclin.52.4.195.
Zotero 插件
